Search clinical trials for: Holmium-166 microspheres

Total 590 results

Terumo Europe N.V.

Recruiting

Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma. (HOMIE-166)

Hepatocellular Carcinoma

Germany
UMC Utrecht

Completed

Radioactive Holmium Microspheres for the Treatment of Liver Metastases (HEPAR)

Liver Tumors | Liver Metastasis

Netherlands
Leiden University Medical Center
Medtronic; ZonMw: The Netherlands Organisation for Health Research and Development and other collaborators

Completed

Holmium Radioembolization as Adjuvant Treatment to RFA for Early Stage HCC: Dose Finding Study (HORA EST HCC)

HCC | Early Stage HCC

Netherlands
UMC Utrecht
Erasmus Medical Center; Dutch Cancer Society; Quirem Medical B.V.

Completed

HEPAR Primary: Holmium-166-radioembolization in Hepatocellular Carcinoma Patients

Hepatocellular Carcinoma | Hepatocellular Carcinoma Non-resectable

Netherlands
Radboud University Medical Center
Terumo Medical Corporation; Quirem Medical B.V.

Recruiting

Percutaneous Holmium Injection in Pancreatic Cancer (SLOTH-2a)

Pancreas Cancer

Netherlands
Poniard Pharmaceuticals

Terminated

A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma

Multiple Myeloma
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma (HOLMBRAVE)

Hepatocellular Carcinoma

France
UMC Utrecht
Erasmus Medical Center; Terumo Corporation

Recruiting

Individualized Dosimetry for Holmium-166-radioembolization in Patients With Unresectable Hepatocellular Carcinoma (iHEPAR)

Hepatocellular Carcinoma Non-resectable

Netherlands
UMC Utrecht

Terminated

Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors (HIT)

Head and Neck Neoplasms | Radioisotopes

Netherlands
Imperial College London
Terumo Europe N.V.

Recruiting

Individualized Dosimetry for Holmium-166 Radioembolization in Patients With Unresectable Hepatocellular Carcinoma (RHEPaiR)

Carcinoma, Hepatocellular

United Kingdom
Erasme University Hospital
Terumo Europe N.V.

Completed

Safety and Feasibility of Radioembolization Using Ho-166 in Patients With Unresectable Hepatocellular Carcinoma (RETOUCH)

Hepatocellular Carcinoma

Belgium
UMC Utrecht

Completed

Radioactive Holmium Microspheres for the Treatment of Unresectable Liver Metastases (HEPAR-2)

Liver Neoplasms

Netherlands
UMC Utrecht

Completed

Holmium-166-radioembolization in NET After Lutetium-177-dotatate; an Efficacy Study (HEPAR_Plus)

Neuroendocrine Tumors

Netherlands
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone

Sarcoma | Metastatic Cancer

United States
UMC Utrecht

Unknown

Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization (SIM)

Liver Diseases | Digestive System Neoplasms | Neoplasm Metastasis | Colorectal Neoplasms

Netherlands
Poniard Pharmaceuticals

Terminated

Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma

Multiple Myeloma

United States, Canada
Terumo Europe N.V.

Terminated

QuiremSpheres Observational Study (Hope166)

Liver, Cancer of, Non-Resectable

Netherlands, Germany
Terumo Europe N.V.

Completed

Holmium-166 Retrospective Collection of Real-World Data (RECORD)

Hepatocellular Carcinoma | Metastatic Cancer

Netherlands, Germany, Switzerland, Belgium, Spain, Portugal, Italy
Radboud University Medical Center
Terumo Medical Corporation

Enrolling by invitation

MRI-guided Holmium-166 Radioembolization (EMERITUS-2)

Primary Liver Cancer | Non-Resectable Hepatocellular Carcinoma

Netherlands
Radboud University Medical Center
Terumo Medical Corporation

Completed

Clinical Validation of a Fractional Administration Device for Holmium-166 SIRT (CONTROL)

Primary Liver Cancer | Liver Cancer | Liver Metastasis Colon Cancer

Netherlands
Gruppo Oncologico del Nord-Ovest

Recruiting

Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients (HAITI)

Colorectal Cancer Metastatic

Italy
The Netherlands Cancer Institute
Universitaire Ziekenhuizen KU Leuven

Recruiting

Radioembolisation and Chemotherapy in Liver Metastatic Breast Cancer Patients (HoLiBreast)

Breast Cancer | Liver Metastases

Netherlands, Belgium
Poniard Pharmaceuticals

Completed

Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
University of Oslo

Unknown

Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.

Magnetic Resonance Imaging, Intestine Small, Crohn Disease.

Norway
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
University of Wisconsin, Madison

Completed

Moses vs. Thulium Laser Study

Urinary Tract Stone

United States
Sheba Medical Center

Unknown

Efficiency of Cold vs. Laser Internal Urethrotomy Treatment of Urethral Strictures (IU)

Urethral Strictures

Israel
Mansoura University

Completed

HoLEP (50W) vs. HoLEP (100W) for Treatment of BPH

Prostatic Hyperplasia

Egypt
University of Wisconsin, Madison

Completed

Clinical Trial Evaluating the Efficiency of Holmium Laser Settings on Urinary Stones

Surgery | Stone Ureter | Stone;Renal

United States
Assiut University

Completed

HoLEP in Management of BPH Patients With Predominant Voiding vs Storage LUTS: A Comparative Retrospective Study

Benign Prostatic Hyperplasia (BPH)

Egypt
Fundación de Investigación Biomédica - Hospital...

Unknown

Prospective, Controlled and Randomized Clinical Trial on Cardiac Cell Regeneration With Laser and Autologous Bone Marrow Stem Cells, in Patients With Coronary Disease and Refractory Angina

Coronary Disease | Angina

Spain
Vanderbilt University Medical Center

Completed

A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology

Nephrolithiasis

United States
The Chaim Sheba Medical Center

Completed

Management of Fragments During Ureteroscopy

Urinary Stones

Israel
University of Kansas Medical Center

Unknown

Duration of Medication Therapy and Outcomes After Holmium Laser Prostate Surgery for Patients With Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

United States
Seoul National University Hospital

Unknown

Low Energy HoLEP on IPSS

Quality of Life | Surgery | Complication of Surgical Procedure | Bladder Outlet Obstruction | Prostatic Hypertrophy | Prostate Hyperplasia
IRCCS San Raffaele

Unknown

Outcomes and Complications of Holmium Laser Enucleation of the Prostate in Expert Hands (ExpHo)

Benign Prostatic Hyperplasia

Italy
Hospital Universitari Vall d'Hebron Research Institute

Recruiting

Application of MOSES Technology in BPH

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia (BPH)

Spain
Menoufia University

Completed

Comparison of High and Low Pulse Energy Dusting Protocols Using Holmium: YAG-laser in Flexible Ureteroscopy for Renal Stones Treatment

Renal Stone

Egypt
University of California, Irvine
Beckman Laser Institute University of California Irvine

Completed

Minimally Invasive Holmium:YAG Laser Blepharoplasty

Lower Eyelid Entropion

United States
Samsung Medical Center

Completed

Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate

Benign Prostatic Hyperplasia (BPH)

Korea, Republic of
Radboud University Medical Center
Quirem Medical B.V.

Completed

Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer (SLOTH-1)

Pancreas Cancer

Netherlands
Thunder Bay Regional Health Research Institute

Recruiting

TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors

Urolithiasis of Bladder

Canada
Thunder Bay Regional Health Research Institute

Recruiting

Thulium Fiber Laser (TFL) Versus Holmium MOSES Laser for Ureteroscopic Management of Kidney Stones

Kidney Stone

Canada
Hospital Regional de Alta Especialidad del Bajio
Braulio Omar Manzo Pérez; Edson Dazaeb Flores Hernández; Pompeyo Stalin Alarcón...

Unknown

Holmium Vs Trilogy Kidney Stones GUY's 1-2 (TriHolmium)

Kidney Diseases | Kidney Calculi | Kidney Stone

Mexico
University of Kansas Medical Center

Recruiting

HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer (HOLEP-RTPC)

Lower Urinary Tract Symptoms | Prostate Cancer

United States
MaineHealth
Boston Scientific Corporation

Enrolling by invitation

Comparison of Holmium Laser and Thulium Laser for Mini PCNL (HOTLaser)

Nephrolithiasis | Percutaneous Nephrolithotomy

United States
Diskapi Teaching and Research Hospital

Unknown

Comparison of Safety and Efficiency of 20w and 30w Holmium Laser Device in Management of 2-3 cm Diameter Kidney Stones With Retrograde Intrarenal Surgery

Nephrolithiasis

Turkey
Marmara University

Recruiting

Association of Urine BDNF and NGF With Lower Urinary System Parameters

Lower Urinary Tract Obstructive Syndrome | Benign Prostatic Hyperplasia With Outflow Obstruction

Turkey
KYU-SUNG LEE
Samsung Medical Center

Completed

Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia

Overactive Detrusor | Benign Prostatic Hypertrophy With Outflow Obstruction

Korea, Republic of

Search clinical trials for: Holmium-166 microspheres

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations